Chronic

FDA Clears the Way for Generic Versions of Transdermal Patches to Treat Chronic Pain

The Food and Drug Administration (FDA) has granted approval to Mylan Technologies, Inc., for the first generic version of Alza Corporation's Duragesic Patch (Fentanyl Transdermal System) used to treat patients suffering from severe chronic pain that cannot be managed with alternative analgesics. When applied to the skin, this patch technology delivers fentanyl, an opioid pain medication that is s...

B cells are required for development of epithelial cancer associated with chronic inflammation

Chronic inflammation is linked to the development of certain types of cancer, but mechanisms mediating inflammation during premalignancy are not well understood. A new research study published in the May issue of Cancer Cell identifies B lymphocytes as important regulators of premalignancy associated with chronic inflammation. The results suggest that drugs targeted against B lymphocytes or recru...

Chronic Sinus Infection Thought To Be Tissue Issue, Mayo Clinic Scientists Show It's Snot

Mayo Clinic researchers have found that the cause of chronic sinus infections lies in the nasal mucus -- the snot -- not in the nasal and sinus tissue targeted by standard treatment. The findings will be published in the August issue of Journal of Allergy and Clinical Immunology and "This strikingly teaches against...

FDA Approves New Treatment for Chronic Hepatitis B

The Food and Drug Administration (FDA) announced the approval of Baraclude (entecavir) tablets and oral solution for the treatment of chronic hepatitis B in adults. Chronic hepatitis B is a serious disease caused by the hepatitis B virus (HBV) that attacks the liver. The virus can cause lifelong infection, cirrhosis (scarring) of the liver, liver cancer, liver failure, and death. According to the...

UQ scientists break new ground in fight against infection & chronic disease

University of Queensland (UQ) researchers are on track to develop new treatments for acute infections, chronic inflammatory diseases and cancer. The discovery, made by four resea...

More>>

Chronic at Biology Products

No data found

Search Chronic biology products at Google

Search Chronic biology products at Yahoo

Search Chronic biology products at Msn

Chronic at Biology Technology

No data found

Search Chronic biology technology at Google

Search Chronic biology technology at Yahoo

Search Chronic biology technology at Msn

Chronic at Medicine News

Roller coasters – cause “Chronic Headache?

Startling findings reveal that the highly popular roller coaster rides that are invading all our amusement parks may not be safe after all! A kind of posttraumatic migraine might be induced on account the seemingly safe rides. In a specific incident that was studied by researchers, following one such ride a young lady presented with throbbing headache, blurred vision and nausea, immediatel...

TIZANIDINE - New solution to chronic headache

Chronic headache is one of the common neurological problems affecting greater amount of population. Most are not due to any underlying disease. If you happen to be one of the unfortunates suffering from this chronic migraine, then there is a reason to celebrate. Yes, the drug used to treat muscle spasms may provide new hope for millions of people who suffer from frequent headaches. Ameri...

Analgesic abuse - cause for chronic headache in children

Over the counter pain medications such as aspirin, acetaminophen(paracetamol) etc., is now identified to be the cause of chronic headache in children. A team of Israeli researchers who treated 26 adolescents, found that the average number of tablets taken by each patient was 28 each week, with 16 using pain medication daily. They stopped all the analgesic medications and found that the h...

Hyperflexible joints connected to chronic fatigue

According to a new study children and teens with chronic fatigue syndrome are three and a half times more likely to have hyperflexible joints than their healthy counterparts.// Researchers from Johns Hopkins Children's Center in Baltimore examined 100 children, ages 10 and older, for joint hypermobility. The group was split evenly between patients diagnosed with CFS and otherwise healthy children...

In Chronic Diseases - Poor compliance of Patients with drug treatment

A WHO report from Geneva has shown that Only approximately 50% of patients in developed countries are compliant and adhere to treatment in chronic diseases and this is even lower in developing countries. The compliance of patients to adhere to the long-term treatment medication of diseases such as cardiovascular diseases, HIV/AIDS, or depression, is poor. In the findings of the WHO’s new...

More>>

Chronic at Medicine Products

SURGITIEtrade; Ligating Loop with Chronic Gut Suture

Description:Surgitie&trade Single Use Ligating Loops with Delivery System...
Company:Autosuture

SURGITIEtrade; Chronic Gut Suture

Description:Surgitie&trade Single Use Ligating Loops with Delivery System...
Company:Autosuture

Chromosome Analysis, Chronic Lymphocytic Leukemia (CLL) Panel by FISH

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

Chronic Lymphocytic Leukemia (CLL)

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

Chronic Bullous Disease

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

More>>

Chronic at Medicine Technology

Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis

TAMPA, Fla.--(BUSINESS WIRE)--Jun 28, 2007 - AccentiaBiopharmaceuticals, Inc. (NASDAQ: ABPI) announced on Wednesday,June 27 at the Jefferies Healthcare Conference that its interimanalysis of the blinded data on the first fifty patients in theFast-Tracked Phase 3 clinical study of SinuNase(TM), at 8 weekspost-randomization, has demonstrated substantial improvement inresolution of one or both...

Second Phase III Study Evaluating Gilead's Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint

FOSTER CITY, Calif.--(BUSINESS WIRE)--June 25, 2007--GileadSciences, Inc. (Nasdaq:GILD) today announced that Study 103, aPhase III clinical trial evaluating the company's once-dailyanti-HIV drug Viread(R) (tenofovir disoproxil fumarate or tenofovirDF) 300 mg as a potential treatment for chronic hepatitis B virus(HBV) infection, met its primary efficacy endpoint. The data showthat Viread...

Second Phase III Study Evaluating Gilead's Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint

FOSTER CITY, Calif.--(BUSINESS WIRE)--Jun 25, 2007 - GileadSciences, Inc. (Nasdaq:GILD) today announced that Study 103, aPhase III clinical trial evaluating the company's once-dailyanti-HIV drug Viread(R) (tenofovir disoproxil fumarate or tenofovirDF) 300 mg as a potential treatment for chronic hepatitis B virus(HBV) infection, met its primary efficacy endpoint. The data showthat Viread is...

Neurogen Announces Positive Results for Proprietary Insomnia Drug in Two Chronic Insomnia Clinical Trials

BRANFORD, Conn.--(BUSINESS WIRE)--Jun 25, 2007 - NeurogenCorporation (Nasdaq: NRGN) today announced positive top-lineresults from two dose-ranging, Phase 2b clinical trials in chronicinsomnia patients with the Company's proprietary insomnia agent,NG2-73, an alpha-3 preferring GABA(A) partial agonist. Multipleformulations were studied in each trial to determine the bestprofile for rapidity o...

Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule, Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for Clinical Development in Chronic Hepatitis C Virus Infection

SAN DIEGO, June 20, 2007 /PRNewswire-FirstCall/ -- AnadysPharmaceuticals, Inc. , a biopharmaceutical company committed tothe discovery, development and commercialization of novel medicinesfor the treatment of hepatitis and cancer, announced today that ithas nominated ANA598 as a candidate for clinical development as anorally-administered direct antiviral for the treatment of chronichepat...

More>>

Chronic at Medicine Dictionary

Chronic urethritis

You are here : l <a href="/ ?q...

Chronic thyroiditis

that frequently results in <a href="/ ?q=/ Medicine-Dictionary/ hypothyroidism" c...

Chronic renal failure

Chronic renal fa...

Chronic Pelvic Pain

<a href="/ ?q=/ Medicine-Dictionary/ pain"...

Chronic pancreatitis

cause...

More>>